ION582
ION582-CS2
Phase 3 small_molecule active
Quick answer
ION582 for Angelman Syndrome is a Phase 3 program (small_molecule) at IONIS PHARMACEUTICALS INC with 2 ClinicalTrials.gov record(s).
Program details
- Company
- IONIS PHARMACEUTICALS INC
- Indication
- Angelman Syndrome
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active